» Articles » PMID: 27999319

Exercise and Beta-Glucan Consumption (Saccharomyces Cerevisiae) Improve the Metabolic Profile and Reduce the Atherogenic Index in Type 2 Diabetic Rats (HFD/STZ)

Abstract

Physical activity and the ingestion of dietary fiber are non-drug alternatives commonly used as adjuvants to glycemic control in diabetic individuals. Among these fibers, we can highlight beta-glucans. However, few studies have compared isolated and synergic effects of physical exercise and beta-glucan ingestion, especially in type 2 diabetic rats. Therefore, we evaluated the effects beta-glucan () consumption, associated or not to exercise, on metabolic parameters of diabetic Wistar rats. The diabetes (DM) was induced by high-fat diet (HFD) associated with a low dose of streptozotocin (STZ-35 mg/kg). Trained groups were submitted to eight weeks of exercise in aquatic environment. In the last 28 days of experiment, animals received 30 mg/kg/day of beta-glucan by gavage. Isolated use of beta-glucan decreased glucose levels in fasting, Glycated hemoglobin (HbA1c), triglycerides (TAG), total cholesterol (TC), low-density lipoprotein (LDL-C), the atherogenic index of plasma. Exercise alone also decreased blood glucose levels, HbA1c, and renal lesions. An additive effect for reducing the atherogenic index of plasma and renal lesions was observed when both treatments were combined. It was concluded that both beta-glucan and exercise improved metabolic parameters in type 2 (HFD/STZ) diabetic rats.

Citing Articles

Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes.

Iatcu O, Hamamah S, Covasa M Nutrients. 2024; 16(20).

PMID: 39458444 PMC: 11510484. DOI: 10.3390/nu16203447.


Comparing prophylactic effect of exercise and metformin on cognitive brain functions in rats with type 3 diabetes mellitus.

Sakr H, Amen M, Rashed L, Khowailed A, Sayed H, Motawee M Arch Med Sci. 2024; 20(2):618-631.

PMID: 38757028 PMC: 11094824. DOI: 10.5114/aoms.2020.99023.


Novel nutraceutical supplements with yeast β-glucan, prebiotics, minerals, and (silymarin) ameliorate obesity-related metabolic and clinical parameters: A double-blind randomized trial.

Nehmi-Filho V, Santamarina A, de Freitas J, Trarbach E, Rodrigues de Oliveira D, Palace-Berl F Front Endocrinol (Lausanne). 2023; 13:1089938.

PMID: 36778595 PMC: 9912840. DOI: 10.3389/fendo.2022.1089938.


An important polysaccharide from fermentum.

Lin B, Huang G Food Chem X. 2022; 15:100388.

PMID: 36211774 PMC: 9532711. DOI: 10.1016/j.fochx.2022.100388.


The Symbiotic Effect of a New Nutraceutical with Yeast β-Glucan, Prebiotics, Minerals, and (Silymarin) for Recovering Metabolic Homeostasis via , , and Gene Expression in a Type-2 Diabetes Obesity Model.

Santamarina A, Macedo Moraes R, Filho V, Murata G, de Freitas J, Miranda D Antioxidants (Basel). 2022; 11(3).

PMID: 35326098 PMC: 8944780. DOI: 10.3390/antiox11030447.


References
1.
Stevens J, Khunti K, Harvey R, Johnson M, Preston L, Woods H . Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Res Clin Pract. 2015; 107(3):320-31. DOI: 10.1016/j.diabres.2015.01.027. View

2.
Sonck E, Stuyven E, Goddeeris B, Cox E . The effect of beta-glucans on porcine leukocytes. Vet Immunol Immunopathol. 2009; 135(3-4):199-207. DOI: 10.1016/j.vetimm.2009.11.014. View

3.
Kahn S, Cooper M, Del Prato S . Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2013; 383(9922):1068-83. PMC: 4226760. DOI: 10.1016/S0140-6736(13)62154-6. View

4.
Forbes J, Cooper M . Mechanisms of diabetic complications. Physiol Rev. 2013; 93(1):137-88. DOI: 10.1152/physrev.00045.2011. View

5.
Gleissner C, Galkina E, Nadler J, Ley K . Mechanisms by which diabetes increases cardiovascular disease. Drug Discov Today Dis Mech. 2008; 4(3):131-140. PMC: 2504760. DOI: 10.1016/j.ddmec.2007.12.005. View